Improving breast cancer services for African-American women living in St. Louis Lailea NoelShahnjayla K. ConnorsSarah Gehlert Preclinical study Open access 26 September 2015 Pages: 5 - 12
Prognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancers Hyeong-Gon MoonKeunhee OhDong-Young Noh Preclinical study 05 October 2015 Pages: 13 - 22
FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index Christina YauLaurence MeyerChristopher C. Benz Preclinical Study 12 October 2015 Pages: 23 - 32
Paclitaxel-induced transcriptional regulation of Fas signaling pathway is antagonized by dexamethasone Martin CrozierLisa A. Porter Preclinical Study 13 October 2015 Pages: 33 - 44
Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer Victoria PompCornelia LeoZsuzsanna Varga Preclinical study 14 October 2015 Pages: 45 - 55
Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis Alimujiang WushouYi-Zhou JiangZhi-Ming Shao Preclinical Study 17 October 2015 Pages: 57 - 62
Osteopontin promotes aromatase expression and estradiol production in human adipocytes Lukas LeitnerAlexander JüretsThomas M. Stulnig Preclinical study 20 October 2015 Pages: 63 - 69
Is a higher boost dose of radiation necessary after breast-conserving therapy for patients with breast cancer with final close or positive margins? Betro T. SadekGelareh HomayounfarAlphonse G. Taghian Clinical trial 29 September 2015 Pages: 71 - 79
Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups Katharine YaoRobert GoldschmidtMassimo Cristofanilli Clinical trial Open access 30 September 2015 Pages: 81 - 88
Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute Denise A. YardleyLinda D. BossermanJohn D. Hainsworth Clinical trial 12 October 2015 Pages: 89 - 97
Complete blood counts, liver function tests, and chest x-rays as routine screening in early-stage breast cancer: value added or just cost? Raphael J. LouieJennifer E. TonnesonKari M. Rosenkranz Clinical trial 14 October 2015 Pages: 99 - 103
Depressive episodes, symptoms, and trajectories in women recently diagnosed with breast cancer Annette L. StantonJoshua F. WileyKaren L. Weihs Epidemiology 29 September 2015 Pages: 105 - 115
Black breast cancer survivors experience greater upper extremity disability Lorraine T. DeanAngela DeMicheleJun J. Mao Epidemiology 29 September 2015 Pages: 117 - 125
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy Grazia ArpinoCarmine De AngelisSabino De Placido Epidemiology Open access 30 September 2015 Pages: 127 - 132
Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer Gregory S. CalipJudith A. MalmgrenHenry G. Kaplan Epidemiology 08 October 2015 Pages: 133 - 143
Hormone-related pathways and risk of breast cancer subtypes in African American women Stephen A. HaddadKathryn L. LunettaJulie R. Palmer Epidemiology 12 October 2015 Pages: 145 - 154
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations Jeffrey S. RossSiraj M. AliMassimo Cristofanilli Epidemiology 12 October 2015 Pages: 155 - 162
Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers? John SempleKelly A. Metcalfethe Hereditary Breast Cancer Clinical Study Group Epidemiology 14 October 2015 Pages: 163 - 169
Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age Jan C. DroogerDelal AkdenizAgnes Jager Epidemiology Open access 14 October 2015 Pages: 171 - 180
onlineDeCISion.org: a web-based decision aid for DCIS treatment Elissa M. OzanneKatharine H. SchneiderRinaa S. Punglia Epidemiology 16 October 2015 Pages: 181 - 190
The readability of online breast cancer risk assessment tools Sarah CortezMelissa MilbrandtGraham Colditz Epidemiology Open access 16 October 2015 Pages: 191 - 199
Explicating perceived barriers to mammography for the USCREEN project: concerns about breast implants, faith violations, and perceived recommendations Jakob D. JensenChelsea RatcliffSherrie Loewen Brief Report 30 September 2015 Pages: 201 - 207
Real-life decision-making impact of Oncotype DX Gianfilippo BertelliSimon Holt Letter to the Editor 15 October 2015 Pages: 209 - 210
Response to real-life decision-making impact of oncotype DX Federico AugustovskiNatalie SotoAgustÃn Ciapponi Rebuttal Letter 16 October 2015 Pages: 211 - 211
